AstraZeneca PLC (id:3195 AZN)
10,474.00 GBP
Opening hours: 08:00 - 16:30 (GMT Standard Time: 11/22/2024 5:35:12 PM)
Exchange closed, opens in 2 days 14 hours
About AstraZeneca PLC
Market Capitalization 158.55B
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
| Headquarters (address) |
1 Francis Crick Avenue Cambridge CB2 0AA United Kingdom |
| Phone | 44 20 3749 5000 |
| Website | https://www.astrazeneca.com |
| Employees | 89,900 |
| Sector | Healthcare |
| Industry | Drug Manufacturers General |
| Ticker | AZN |
| Exchange | London Stock Exchange |
| Currency | GBP |
| 52 week range | 9,461.00 - 13,388.00 |
| Market Capitalization | 158.55B |
| Dividend yield forward | 3.10 % |
| Dividend yield forward United Kingdom (ID:3, base:499) | 7.31 % |
| P/E trailing | 30.32 |
| P/E forward | 13.73 |
| Price/Sale | 3.10 |
| Price/Book | 377.43 |
| Beta | 0.180 |
| EPS | 3.27 |
| EPS United Kingdom (ID:3, base:637) | 0.428 |
Dividend growth streak
AstraZeneca PLC has raised their dividend 2.00 years in a row. This is below the 4.481461 year average in the 'Drug Manufacturers General' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: AstraZeneca PLC has raised their dividend 3.10 years in a row. This is below the 41168.086700 year average in the 'Drug Manufacturers General' industry
Compound Average Growth Rate 3 Years
Compound Average Growth Rate 3 Years: AstraZeneca PLC has raised their dividend 2.79 years in a row. This is below the 24.005000 year average in the 'Drug Manufacturers General' industry
Compound Average Growth Rate 5 Years
Compound Average Growth Rate 5 Years: AstraZeneca PLC has raised their dividend 3.04 years in a row. This is below the 12.571400 year average in the 'Drug Manufacturers General' industry
Compound Average Growth Rate 10 Years
Compound Average Growth Rate 10 Years: AstraZeneca PLC has raised their dividend 2.70 years in a row. This is below the 10.153400 year average in the 'Drug Manufacturers General' industry
Payout Ratio
Payout Ratio: AstraZeneca PLC has raised their dividend 72.14 years in a row. This is below the 147.100200 year average in the 'Drug Manufacturers General' industry
Self funded year
AstraZeneca PLC years needed to self fund. This is above the 62.385563 year average in the 'Drug Manufacturers General' industry
Dividend growth streak
AstraZeneca PLC has raised their dividend 2.00 years in a row. This is below the 4.481461 year average in the 'Drug Manufacturers General' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: AstraZeneca PLC has raised their dividend 3.10 years in a row. This is below the 41168.086700 year average in the 'Drug Manufacturers General' industry
Compound Average Growth Rate 3 Years
Compound Average Growth Rate 3 Years: AstraZeneca PLC has raised their dividend 2.79 years in a row. This is below the 24.005000 year average in the 'Drug Manufacturers General' industry
Compound Average Growth Rate 5 Years
Compound Average Growth Rate 5 Years: AstraZeneca PLC has raised their dividend 3.04 years in a row. This is below the 12.571400 year average in the 'Drug Manufacturers General' industry
Compound Average Growth Rate 10 Years
Compound Average Growth Rate 10 Years: AstraZeneca PLC has raised their dividend 2.70 years in a row. This is below the 10.153400 year average in the 'Drug Manufacturers General' industry
Payout Ratio
Payout Ratio: AstraZeneca PLC has raised their dividend 72.14 years in a row. This is below the 147.100200 year average in the 'Drug Manufacturers General' industry
Self funded year
AstraZeneca PLC years needed to self fund. This is above the 62.385563 year average in the 'Drug Manufacturers General' industry